Episode 138: Perplexity exits ads, Epsilon owns an SSP, and Paramounts Looks at The Free Press

Marketecture: Get Smart. Fast.

In this episode of the Marketecture Podcast, hosts Ari Paparo and Eric Franchi discuss the recent Google search remedies and their implications for the market. They delve into the antitrust issues surrounding Google, the upcoming ad tech trial, and the complexities of Epsilon's SSP. The conversation also touches on Perplexity's struggles in advertising, OpenAI's strategic acquisition, and emerging trends in ad tech and AI. Additionally, they explore insights from the CTV landscape, including Roku's growth and the NFL Red Zone's new commercial strategy, concluding with a discussion on Paramount's potential acquisition of The Free Press.

Takeaways

• Google's market share remains unchanged despite antitrust remedies.
• Data sharing with competitors raises privacy concerns.
• AI is a significant competitor to Google search.
• The ad tech trial may see Google settling sooner.
• Agencies are unaware of buying from competitors' SSPs.
• Perplexity's advertising efforts are still experimental.
• OpenAI's acquisition signals a strong move in ad tech.
• Roku surpasses broadcast TV in viewing share.
• NFL Red Zone's introduction of commercials sparks controversy.
• Paramount's potential acquisition of The Free Press indicates market value.

Chapters

00:00Introduction and Overview of Google Search Remedies

03:00Antitrust Implications and Market Dynamics

05:54Ad Tech Trial and Its Consequences

08:53Epsilon's SSP and Agency Dynamics

11:42Perplexity's Advertising Challenges

14:48OpenAI's Acquisition and Strategic Moves

17:54Emerging Trends in Ad Tech and AI

20:43CTV Insights and NFL Red Zone Controversy

23:46Paramount's Potential Acquisition of The Free Press

Learn more about your ad choices. Visit megaphone.fm/adchoices